Literature DB >> 6336982

Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review.

J J Brooks, H T Enterline.   

Abstract

A large series of primary gastric lymphomas with long-term follow-up (average, 12.8 years) is reported. A number of factors known to affect nodal lymphoma were examined. Five- and ten-year survival rates were 57 and 46%, respectively. Statistically significant favorable prognostic variables were smaller tumor size (less than or equal to 7 cm), superficial mural invasion (submucosal only), and pathologic Stage I disease; these variables were intimately interrelated. A favorable influence on survival was discerned concerning histologic type and nodular histology, although still below statistical significance. No significant relation to survival was observed concerning clinical weight loss or palpable mass, vascular invasion, mode of therapy, or histologic subtypes of "histocytic" lymphoma. Of patients who succumbed to disease, 75% did so within two years (average, 1.8 years); however, later recurrence and death may occur. An argument for resection of localized disease is presented. Mitotic index and nuclear diameter were of diagnostic importance, and associated lesions such as pseudolymphomas are discussed in relation to pathogenesis. Histologic variation within tumors suggested visualization of clonal development in non-Hodgkin's lymphomas.

Entities:  

Mesh:

Year:  1983        PMID: 6336982     DOI: 10.1002/1097-0142(19830215)51:4<701::aid-cncr2820510425>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

Review 1.  Common emergencies in cancer medicine: hematologic and gastrointestinal syndromes.

Authors:  C R Thomas; I K Carter; W T Leslie; F Sutton
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

2.  Gastric "pseudolymphoma" with restricted light chain expression in a patient with obscure gastrointestinal blood loss.

Authors:  H Schulman; J Sickel; M S Kleinman; J T Adams
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

Review 3.  Primary Gastric Hodgkin's Lymphoma: An Extremely Rare Entity and A Diagnostic Challenge.

Authors:  Saurabh Sethi; John Patrick Higgins; Daniel A Arber; Brendan Visser; Subhas Banerjee
Journal:  Dig Dis Sci       Date:  2015-03-12       Impact factor: 3.199

4.  Primary gastric non-Hodgkin's lymphomas in Japan.

Authors:  N Mohri
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Malignant lymphoma of the gastrointestinal tract and mesentery. A clinico-pathologic study of the significance of histologic classification. NHL Study Group of the Comprehensive Cancer Center West.

Authors:  J H van Krieken; R Otter; J Hermans; K van Groningen; P J Spaander; M M van de Sandt; J F Keuning; P M Kluin
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

6.  Malignant gastric lymphoma with spontaneous perforation.

Authors:  Satoko Shimada; Tokichi Gen; Hiroyuki Okamoto
Journal:  BMJ Case Rep       Date:  2013-01-17

7.  [Status of gastrectomy in the multi-modality therapy concept of primary non-Hodgkin's lymphoma of the stomach].

Authors:  P R Verreet; F Borchard; H Stöltzing; K Thon; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1990

8.  Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice.

Authors:  A Enno; J O'Rourke; S Braye; R Howlett; A Lee
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach.

Authors:  J K Chan; C S Ng; P G Isaacson
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

10.  Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue.

Authors:  R Villuendas; M A Piris; J L Orradre; M Mollejo; R Rodriguez; M Morente
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.